化合物CCT 031374 hydrobromide T21685
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 1219184-91-4 | ¥3,820.00 | 询底价 |
10 mg | 1219184-91-4 | ¥2,290.00 | 询底价 |
50 mg | 1219184-91-4 | ¥5,450.00 | 询底价 |
2 mg | 1219184-91-4 | ¥918.00 | 询底价 |
100 mg | 1219184-91-4 | ¥7,430.00 | 询底价 |
5 mg | 1219184-91-4 | ¥1,530.00 | 询底价 |
500 mg | 1219184-91-4 | ¥14,800.00 | 询底价 |
1 mg | 1219184-91-4 | ¥625.00 | 询底价 |
1 mL | 1219184-91-4 | ¥1,750.00 | 询底价 |
Product Introduction
Bioactivity
英文名: CCT 031374 hydrobromide
描述: CCT 031374 hydrobromide 是一种 TCF/β-catenin 抑制剂,具有抗肿瘤活性。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 55 mg/mL (126.63 mM)
关键字: inhibit | CCT031374 Hydrobromide | Beta catenin | CCT031374 | CCT-031374 Hydrobromide | CCT 031374 hydrobromide | CCT-031374 | Inhibitor | CCT 031374 | β-catenin | CCT 031374 Hydrobromide
相关产品: TNIK-IN-5 | Wnt pathway activator 2 | ICG001 | Fz7-21 | Astragaloside I | FzM1 | L-quebrachitol | Wnt pathway activator 1 | TNKS-2-IN-2 | KY1220
相关库: Anti-Cancer Metabolism Compound Library | Anti-Cancer Compound Library | Neuronal Differentiation Compound Library | Anti-Ovarian Cancer Compound Library | Inhibitor Library | Cytoskeletal Signaling Pathway Compound Library | Anti-Colorectal Cancer Compound Library | Anti-Cancer Active Compound Library | Stem Cell Differentiation Compound Library | Bioactive Compound Library
化合物CCT 031374 hydrobromide T21685信息由TargetMol中国为您提供,如您想了解更多关于化合物CCT 031374 hydrobromide T21685报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途